Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Canagliflozin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,770Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/10/2025 Alembic Pharmaceuticals Limited
    India
    		 Classia Co., Ltd. Su758-16-ND Canagliflozin 2024-10-15 Alembic Pharmaceutical limited Unit-III India API Unit-III, Survey No.: 842, 843, Village - Karakhadi, Taluka - Padra, Dist. Vadodara-391 450, Gujarat, India.
    31/10/2025 Alembic Pharmaceuticals Limited
    India
    		 Darim Biotech Co., Ltd. Su758-16-ND(1) Canagliflozin 2025-03-11 Alembic Pharmaceutical limited Unit-III India API Unit-III, Survey No.: 842, 843, Village - Karakhadi, Taluka - Padra, Dist. Vadodara-391 450, Gujarat, India.